All Series
76 series
All Series
Roundtable
Lung Cancer
ALK-Positive Metastatic NSCLC: Where Are We Now
Roundtable
Hepatobiliary Cancer
Immunotherapy Strategies for Hepatobiliary Cancers
Roundtable
Breast Cancer
Next-Generation Therapies for Metastatic HR-Positive Breast Cancer
Roundtable
Lung Cancer
First-Line Immunotherapy for Metastatic NSCLC Special Populations and Unmet Needs
Roundtable
Lung Cancer
Clinical Perspectives on KRAS-Mutant NSCLC
Roundtable
Hematologic Malignancies
Personalizing Therapy for Myelofibrosis
Roundtable
Hematologic Malignancies
Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease
Roundtable
Lymphoma
Evolving Treatment Landscape of Indolent Lymphoma
Roundtable
Breast Cancer
Evolving Paradigms in the Treatment of HR-Positive HER2-Positive Metastatic Breast Cancer
Roundtable
Lung Cancer
EGFR-Mutant NSCLC Treatment Considerations for Early-Stage Disease
Roundtable
Breast Cancer
PI3K Inhibition Strategies for HR-Positive HER2-Negative Metastatic Breast Cancer
Roundtable
Bladder Cancer
Immunotherapy Approaches in Muscle-Invasive Bladder Cancer
Roundtable
Kidney Cancer
New Approaches to Treatment Sequencing in Advanced Renal Cell Carcinoma
Roundtable
Lymphoma
Treatment Approaches to Relapsed Refractory CLL What Comes Next
Roundtable
Leukemia
Navigating the Complexities of Relapsed Refractory AML
Roundtable
Hematologic Malignancies
Expert Perspectives on the Treatment of High-Risk Myelofibrosis
Roundtable
Breast Cancer
Novel Therapies for HER2-Positive Breast Cancer Brain Metastases
Roundtable
Breast Cancer
The Role of Oral SERDs in Metastatic Breast Cancer
Roundtable
Gastrointestinal Cancer
Evolving Treatment Paradigms for Neuroendocrine Tumors
Roundtable
Prostate Cancer
Targeted Approaches to Metastatic Hormone-Sensitive Prostate Cancer
Roundtable
Lung Cancer
Emerging Treatment Options for Small Cell Lung Cancer
Roundtable
Gynecologic Cancers
Targeted Treatment Options in Platinum-Resistant Ovarian Cancer
Roundtable
Hepatobiliary Cancer
First-Line Systemic Treatment of Advanced Hepatobiliary Cancers
Roundtable
CNS Cancers
Personalizing Therapy for Patients With Glioma
Roundtable
Multiple Myeloma
Navigating the T-Cell Therapy Landscape in Multiple Myeloma
Roundtable
Hematologic Malignancies
Optimizing Management of Myelofibrosis Balancing Watchful Waiting and Early Action (1)
Roundtable
Breast Cancer
Managing Cardiovascular Risk in Metastatic Breast Cancer Clinical Insights on CDK4/6 Inhibitors
Roundtable
Lymphoma
Personalizing Treatment Pathways in Relapsed/Refractory DLBCL
Roundtable
Lung Cancer
Optimizing the Care Continuum for EGFR-Mutant NSCLC
Roundtable
Gynecologic Cancers
Navigating the Immunotherapy Landscape in Advanced Recurrent Endometrial Cancer
Roundtable
Breast Cancer
Collaboration in Managing Targeted Therapy for HR-Positive HER2-Negative Breast Cancer
Roundtable
Prostate Cancer